CIK: 0002011385 · Show all filings
Period: Q4 2024 (← Previous) (Next →)
Filing Date: Feb 14, 2025
Total Value ($000): $115,892 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MLYS | Mineralys Therapeutics, Inc. | 8,644,579 | $106,415 | 91.8% | $7.85 | +66.5% | COM | 603170101 |
| PHAT | Phathom Pharmaceuticals, Inc. | 1,167,114 | $9,477 | 8.2% | $10.60 | +16.8% | COM | 71722W107 |